LARP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.144200E-01
Normal-vs-Stage2
9.702200E-01
Normal-vs-Stage3
1.442350E-01
Normal-vs-Stage4
5.900200E-01
Stage1-vs-Stage2
6.058000E-01
Stage1-vs-Stage3
2.319800E-02
Stage1-vs-Stage4
6.922000E-01
Stage2-vs-Stage3
7.494200E-02
Stage2-vs-Stage4
4.172600E-01
Stage3-vs-Stage4
9.171800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.563800E-01
Normal-vs-AfricanAmerican
6.296200E-01
Normal-vs-Asian
8.392200E-01
Caucasian-vs-AfricanAmerican
4.725000E-01
Caucasian-vs-Asian
5.486000E-01
AfricanAmerican-vs-Asian
8.559600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.985200E-01
Normal-vs-Female
9.115600E-01
Male-vs-Female
3.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.412200E-01
Normal-vs-Age(41-60Yrs)
5.736400E-01
Normal-vs-Age(61-80Yrs)
8.978600E-01
Normal-vs-Age(81-100Yrs)
6.945600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.256400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.553000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.567200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.302100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.914400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.951400E-01
Normal-vs-Daily Drinker
6.475200E-01
Normal-vs-Weekly Drinker
9.715200E-01
Normal-vs-Occasional Drinker
6.670400E-01
Normal-vs-Social Drinker
5.523800E-01
Non Drinker-vs-Daily Drinker
6.671400E-01
Non Drinker-vs-Weekly Drinker
7.104400E-01
Non Drinker-vs-Occasional Drinker
1.858040E-01
Non Drinker-vs-Social Drinker
1.070620E-01
Daily Drinker-vs-Weekly Drinker
4.988000E-01
Daily Drinker-vs-Occasional Drinker
1.007390E-01
Daily Drinker-vs-Social Drinker
6.310400E-02
Weekly Drinker-vs-Occasional Drinker
4.871600E-01
Weekly Drinker-vs-Social Drinker
3.394200E-01
Occasional Drinker-vs-Social Drinker
6.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.673000E-01
Normal-vs-Grade 2
6.040600E-03
Normal-vs-Grade 3
3.904500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.027600E-01
Grade 1-vs-Grade 3
2.785000E-01
Grade 1-vs-Grade 4
1.673000E-01
Grade 2-vs-Grade 3
1.413000E-01
Grade 2-vs-Grade 4
6.040600E-03
Grade 3-vs-Grade 4
3.904500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.142400E-01
Normal-vs-NonDiabetic
9.371600E-01
Diabetic-vs-NonDiabetic
3.394800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.150800E-01
Normal-vs-NoPancreatitis
9.975800E-01
Pancreatitis-vs-NoPancreatitis
4.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.571200E-01
Normal-vs-N1
9.373400E-01
N0-vs-N1
3.786600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.085200E-01
Normal-vs-TP53-NonMutant
7.714200E-01
TP53-Mutant-vs-TP53-NonMutant
3.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
